arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

ProQR Therapeutics N.V.

PRQR Health Care Biotechnology: Pharmaceutical Preparations
$1.99
▲ +1.0% Today
as of Aug 5, 16:53 ET
Last 30 days +7.65% Jun 29 → Aug 05
$1.64 $1.73 $1.81 $1.90 $1.99 Jun 29 Jul 07 Jul 14 Jul 22 Jul 29 Aug 05
Open
$1.53
High
$1.55
Low
$1.48
Volume
$449,681
Avg Vol
$471,748
Mkt Cap
$241M
P/E (TTM)
—
Beta
—
52w High
$3.10
52w Low
$1.33
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 7 items

Aug 3 · 20:27 MT Newswires
Proqr Therapeutics Insider Bought Shares Worth $353,960, According to a Recent SEC Filing
Jul 6 · 21:38 MT Newswires
ProQR Registers Shares for Resale by Investor
Jun 26 · 12:17 MT Newswires
Chardan Research Adjusts ProQR Therapeutics Price Target to $3 From $4, Maintains Buy Rating
▸ Show all 7 press releases & news Free account →

Overview

52-week range
$1.33
$3.10
37% of range
Avg surprise (last 3)
-32.4%
Avg reaction (last 2)
-0.9%
0% positive
Latest IV / EM
46%
EM ±7.6% · $3 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.65$-0.38$-0.11$0.15$0.42 Actual $-0.11Est $-0.09Actual $-0.14Est $-0.08Actual $-0.15Est $-0.15 Mar/2025Jun/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-0.15 $-0.15 0.0% -36.4% -0.6% earnings
Thu Aug 7, 2025Jun/2025 $-0.14 $-0.08 -75.0% — — earnings
Thu May 8, 2025Mar/2025 $-0.11 $-0.09 -22.2% — -1.3% earnings

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Thu Aug 6, 2026Jun/2026OTHER -$0.14-$0.14 0.0%

Implied volatility — last 90 days

45%806%1567%2329%3090% Jun 08 — IV 1980% · EM ±261.4%Jun 09 — IV 2100% · EM ±263.2%Jun 19 — IV 910% · EM ±201.1%Jun 22 — IV 1012% · EM ±211.4%Jun 23 — IV 537% · EM ±109.8%Jun 24 — IV 1048% · EM ±209.9%Jun 25 — IV 1381% · EM ±270.4%Jun 26 — IV 598% · EM ±114.4%Jun 29 — IV 308% · EM ±54.6%Jun 30 — IV 1168% · EM ±201.1%Jul 01 — IV 582% · EM ±97.1%Jul 02 — IV 1332% · EM ±215.5%Jul 03 — IV 1379% · EM ±215.5%Jul 06 — IV 1586% · EM ±219.7%Jul 07 — IV 1779% · EM ±234.9%Jul 08 — IV 1900% · EM ±238.1%Jul 09 — IV 1876% · EM ±221.6%Jul 10 — IV 915% · EM ±101.2%Jul 13 — IV 1162% · EM ±97.1%Jul 14 — IV 3090% · EM ±223.5%Jul 21 — IV 46% · EM ±10.6%Jul 24 — IV 1302% · EM ±287.8%Jul 28 — IV 387% · EM ±79.1%Jul 30 — IV 100% · EM ±19.6%Jul 31 — IV 1580% · EM ±302.3%Aug 04 — IV 889% · EM ±153.1%Aug 05 — IV 46% · EM ±7.6%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,164.75-0.4%
JNJ
Johnson & Johnson
$624.1B $258.23+0.2%
ABBV
AbbVie Inc.
$454.8B $246.35+0.1%
MRK
Merck & Company, Inc.
$321.6B $129.20+0.7%
PM
Philip Morris International Inc
$299.3B $188.93-0.0%
NVS
Novartis AG
$297.9B $154.440.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in